9 July 2021
Kirkland Advises on $400 Million Hong Kong IPO of Keymed Biosciences
Advising firms
Deal team
1 lawyer named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Mengyu Lu Lead | Kirkland & Ellis | Partner | capital markets | Not stated |
Stated terms
- Stated value
- USD 400m ($400 million)
- What the figure measures
- Issue size
- Client
- Not stated
- Counterparties
- Morgan Stanley (Underwriters)
China International Capital Corporation (Underwriters)
Huatai Financial (Underwriters)
China Everbright Securities (Underwriters)